Kristina Burow

Insider Reports History

Location
Chicago, IL
Signature
/s/ Matthew Lang, Attorney-in-Fact for Kristina M. Burow.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristina Burow:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Director Common Stock 2,345,711 $73,655,325 $31.40 29 May 2025 Indirect
Beam Therapeutics Inc. Director Common Stock 2,721,519 $71,902,532 $26.42 06 Jun 2023 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 12,205,379 $22,213,789 $1.82 27 Oct 2025 By ARCH Venture Fund X, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 11,886,758 $21,633,899 $1.82 27 Oct 2025 By ARCH Venture Fund X Overage, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 6,046,907 $15,782,427 $2.61 27 Oct 2025 By ARCH Venture Fund XII, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 2,321,566 $4,225,250 $1.82 27 Oct 2025 By ARCH Venture Fund VIII Overage, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 1,387,228 $2,524,754 $1.82 27 Oct 2025 By ARCH Venture Fund VII, L.P.
Beam Therapeutics Inc. Director Common Stock 26,011 $687,211 $26.42 06 Jun 2023 Direct
Scholar Rock Holding Corp Director Common Stock 21,071 $628,627 $29.83 29 May 2025 Direct
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 16,532 $403,381 $24.40 06 Jun 2023 Direct
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 47,717 $86,844 $1.82 27 Oct 2025 Direct
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 25,000 $69,250 $2.77 24 Jun 2021 Direct
Metsera, Inc. Director Common Stock 0 $0 $52.33 13 Nov 2025 Direct
Metsera, Inc. Director Common Stock 0 $0 $52.33 13 Nov 2025 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 80,000 28 May 2025 Direct
Gossamer Bio, Inc. Director Stock Option (Right to Buy) 35,000 08 Jun 2023 Direct
Metacrine, Inc. Director Stock Option (right to buy) 16,500 24 May 2021 Direct
Boundless Bio, Inc. Director, 10%+ Owner Stock Option (right to buy) 16,000 23 Jun 2025 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 9,206 22 May 2025 Direct
Metsera, Inc. Director Restricted Stock Unit 2,688 13 Nov 2025 Direct
Metsera, Inc. Director Series A Convertible Preferred Stock 0 03 Feb 2025 Indirect
Metsera, Inc. Director Series B Convertible Preferred Stock 0 03 Feb 2025 Indirect
Metsera, Inc. Director Series Seed Preferred Stock 0 03 Feb 2025 Indirect
Metsera, Inc. Director Stock Option (right to buy) 0 13 Nov 2025 Direct

Insider Reports Filed by Kristina Burow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTSR Metsera, Inc. 13 Nov 2025 8 $0 4 Director 13 Nov 2025, 21:10
NMRA Neumora Therapeutics, Inc. 27 Oct 2025 1 +$4,999,977 4 Director, 10%+ Owner 29 Oct 2025, 19:22
BOLD Boundless Bio, Inc. 23 Jun 2025 1 $0 4 Director, 10%+ Owner 23 Jun 2025, 17:11
SRRK Scholar Rock Holding Corp 29 May 2025 2 -$160,511 4 Director 30 May 2025, 16:31
NMRA Neumora Therapeutics, Inc. 28 May 2025 5 $0 4 Director, 10%+ Owner 30 May 2025, 18:30
SRRK Scholar Rock Holding Corp 22 May 2025 2 $0 4 Director 23 May 2025, 16:45
MTSR Metsera, Inc. 20 May 2025 1 $0 4 Director 22 May 2025, 19:39
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 4 $0 4 Director, 10%+ Owner 18 Feb 2025, 16:30
MTSR Metsera, Inc. 03 Feb 2025 9 +$39,999,996 4 Director, 10%+ Owner 03 Feb 2025, 19:15
MTSR Metsera, Inc. 30 Jan 2025 0 $0 3 Director, 10%+ Owner 30 Jan 2025, 21:42
SRRK Scholar Rock Holding Corp 27 Jun 2024 2 $0 4 Director 01 Jul 2024, 18:19
NMRA Neumora Therapeutics, Inc. 13 Jun 2024 2 $0 4 Director, 10%+ Owner 14 Jun 2024, 16:11
BOLD Boundless Bio, Inc. 02 Apr 2024 12 +$3,200,000 4 Director, 10%+ Owner 04 Apr 2024, 16:30
BOLD Boundless Bio, Inc. 27 Mar 2024 1 $0 4 Director, 10%+ Owner 29 Mar 2024, 16:30
BOLD Boundless Bio, Inc. 27 Mar 2024 0 $0 3 Director, 10%+ Owner 27 Mar 2024, 20:11
SRRK Scholar Rock Holding Corp 21 Dec 2023 2 $0 4 Director 26 Dec 2023, 17:36
NMRA Neumora Therapeutics, Inc. 08 Dec 2023 3 $0 4 Director, 10%+ Owner 12 Dec 2023, 19:52
NMRA Neumora Therapeutics, Inc. 13 Nov 2023 2 +$412,140 4 Director, 10%+ Owner 15 Nov 2023, 18:55
NMRA Neumora Therapeutics, Inc. 08 Nov 2023 5 +$1,543,563 4 Director, 10%+ Owner 13 Nov 2023, 19:01
NMRA Neumora Therapeutics, Inc. 03 Nov 2023 3 +$1,099,945 4 Director, 10%+ Owner 07 Nov 2023, 19:00
NMRA Neumora Therapeutics, Inc. 28 Sep 2023 3 +$1,046,848 4 Director, 10%+ Owner 29 Sep 2023, 19:55
NMRA Neumora Therapeutics, Inc. 26 Sep 2023 2 +$700,464 4 Director, 10%+ Owner 27 Sep 2023, 21:19
NMRA Neumora Therapeutics, Inc. 22 Sep 2023 3 +$1,127,064 4 Director, 10%+ Owner 25 Sep 2023, 22:37
NMRA Neumora Therapeutics, Inc. 19 Sep 2023 13 +$25,500,000 4 Director, 10%+ Owner 20 Sep 2023, 07:23
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 1 $0 4 Director 18 Sep 2023, 18:54
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Director, 10%+ Owner 14 Sep 2023, 21:56
SRRK Scholar Rock Holding Corp 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 07:34
GOSS Gossamer Bio, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:13
BEAM Beam Therapeutics Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 17:02
BEAM Beam Therapeutics Inc. 01 Sep 2022 1 $0 4 Director 02 Sep 2022, 16:06
GOSS Gossamer Bio, Inc. 09 Jun 2022 1 $0 4 Director 15 Jul 2022, 17:21
SRRK Scholar Rock Holding Corp 26 May 2022 1 $0 4 Director 27 May 2022, 16:32
BEAM Beam Therapeutics Inc. 30 Jun 2021 3 $0 4 Director 02 Jul 2021, 17:20
BEAM Beam Therapeutics Inc. 25 Jun 2021 6 $0 4 Director 29 Jun 2021, 17:20
UBX Unity Biotechnology, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 17:12
BEAM Beam Therapeutics Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 07:55
GOSS Gossamer Bio, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 21:01
SRRK Scholar Rock Holding Corp 27 May 2021 1 $0 4 Director 01 Jun 2021, 17:03
/report/000120919121035781-burow-kristina-2021-05-24 Metacrine, Inc. 24 May 2021 1 $0 4 Director 25 May 2021, 18:58